Lively Q&A panel with McKinsey partner Sebastian Sieler, L Catterton managing partner, Chinta Bhagat and Axel Paeger, CEO, Ameos on how to plan and implement change that will really add value to your health care services business.
Max Hotopf, chairman, Healthcare Business International interviews Dimitris Moulavasilis on how Diaverum, an international dialysis player present in 22 countries and four continents has reacted to Covid. We look briefly at Diaverum’s contingency planning before analysing how he sees it impacting on the business with a particular emphasis on what it means for three crucial […]
Making sense of the money markets isn't easy right now. But some big players - Ramsay, Zur Rose and TPG are still raising money and some sectors such as German outpatient are still seeing M&A consolidation.
Finnish outpatient group Terveystalo is working with businesses to create COVID-19 action plans as economies start to open. Meanwhile, corporate and private pay is down 30% in April.
The Induction Switch app is used by the majority of hospital doctors in the UK but its owner has only very recently started generating revenue a year after launching on the AIM. That's despite a userbase stretching South Africa, Australia and the USA. Its CEO, an entrepreneur who has founded no less than three health tech companies, talks to HBI about how it plans to turn free-using customers into revenue-generating customers.
HBI talks to Tony Veverka, CEO of cosmetic surgery specialist Transform Hospital Group, about his business, and the market pre-and (speculatively) post-COVID.
Bupa, the global healthcare insurer and healthcare operator went from pre-tax profits of £502m in 2018 to a loss of £78m in 2019, thanks mainly to huge write-offs in its UK dentistry business and Australian care homes. But stripping out write-offs, underlying profitability still plunged 31%. Revenue rose just 4%. Why, and what does this tell us about Bupa and its future?
Most attempts at innovation in healthcare are still being built with insufficient access to the data that defines the problem. The EU's health innovation arm, EIT Health, is calling for providers to be more data transparent for the sake of policymakers and entrepreneurs. HBI speaks to its CEO and director of innovation about curating data.
With the help of a results-based financing mechanism, Mexico's largest specialised diabetes provider Clínicas del Azúcar has doubled its number of patients from the poorest segments of society and tells HBI it can now double the locations for potential clinics. We speak to its CEO and the co-creator of 'social impact incentives' about how to monetise extra value in impact investing.
Occupational healthcare groups Medicover and Terveystalo are growing revenue at upwards of 25%, much faster than the 6-9% seen in other publicly listed groups so far this year. Historically employer-funded, individual pay is now growing three times faster than corporate. With Fresenius Helios setting out occupational healthcare expansion plans, what is the future of corporate pay?
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.